We are live on ! Find out more
HP

Hikari Power Portfolio holdings

AUM $855M
1-Year Est. Return 14.24%
This Fund
S&P 500
This Quarter Est. Return
+4.68%
1 Year Est. Return
+14.24%
3 Year Est. Return
+53.45%
5 Year Est. Return
+75.51%
10 Year Est. Return
+220.8%
AUM
$774M
AUM Growth
+$32M
Cap. Flow
+$4.48M
Cap. Flow %
0.58%
Top 10 Hldgs %
60.49%
Holding
103
New
9
Increased
21
Reduced
5
Closed
13

Top Buys

Rank Stock Value
1
SGYP
Synergy Pharmaceuticals, Inc Common Stock
SGYP
+$3.41M
2
AMGN icon
Amgen
AMGN
+$2.71M
3
POT
Potash Corp Of Saskatchewan
POT
+$1.87M
4
DVA icon
DaVita
DVA
+$1.41M
5
ESRX
Express Scripts Holding Company
ESRX
+$1.36M

Top Sells

Rank Stock Value
1
SRCL
Stericycle Inc
SRCL
+$6.93M
2
DO
Diamond Offshore Drilling
DO
+$5.46M
3
BA icon
Boeing
BA
+$2.7M
4
CBI
Chicago Bridge & Iron Nv
CBI
+$1.98M
5
OPK icon
Opko Health
OPK
+$917K

Sector Composition

Rank Sector Weight
1 Financials 39.59%
2 Healthcare 25.46%
3 Technology 10.29%
4 Industrials 10.13%
5 Energy 5.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BRK.A icon
1
Berkshire Hathaway Class A
BRK.A
$1.11T
$193M 25.01%
704
+5
+0.7% +$1.33M
WFC icon
2
Wells Fargo
WFC
$264B
$85.2M 11.01%
1,544,420
– –
IBM icon
3
IBM
IBM
$225B
$43.6M 5.63%
314,009
– –
MMM icon
4
3M
MMM
$94.4B
$23.7M 3.06%
134,789
+1,555
+1% +$269K
JNJ icon
5
Johnson & Johnson
JNJ
$626B
$22.6M 2.92%
173,930
+2,030
+1% +$269K
PX
6
DELISTED
Praxair Inc
PX
$21.1M 2.73%
151,020
– –
PSX icon
7
Phillips 66
PSX
$89.5B
$20.8M 2.68%
226,500
+10,800
+5% +$915K
NVO
8
Novo Nordisk
NVO
$207B
$20.4M 2.64%
847,600
– –
RTX icon
9
RTX Corp
RTX
$302B
$18.7M 2.41%
255,511
+11,282
+5% +$835K
DVA icon
10
DaVita
DVA
$11.4B
$18.5M 2.4%
312,300
+23,400
+8% +$1.41M
DHR icon
11
Danaher
DHR
$146B
$18.5M 2.39%
243,422
– –
POT
12
DELISTED
Potash Corp Of Saskatchewan
POT
$18.1M 2.34%
940,900
+104,700
+13% +$1.87M
V icon
13
Visa
V
$677B
$18.1M 2.34%
171,900
– –
ROP icon
14
Roper Technologies
ROP
$39.5B
$17.2M 2.22%
70,600
– –
BA icon
15
Boeing
BA
$184B
$16.3M 2.11%
64,300
-11,600
-15% -$2.7M
AGN
16
DELISTED
Allergan plc
AGN
$14.6M 1.89%
71,400
– –
WAB icon
17
Wabtec
WAB
$50.3B
$13.9M 1.8%
183,300
+12,100
+7% +$931K
NOV icon
18
NOV
NOV
$7.49B
$11.9M 1.54%
333,800
+40,400
+14% +$1.32M
GILD icon
19
Gilead Sciences
GILD
$168B
$11.5M 1.49%
141,930
+12,600
+10% +$963K
AMGN icon
20
Amgen
AMGN
$224B
$10.8M 1.4%
57,970
+15,270
+36% +$2.71M
FTV icon
21
Fortive
FTV
$18.6B
$10M 1.3%
224,703
– –
WAT icon
22
Waters Corp
WAT
$40.7B
$9.3M 1.2%
51,800
– –
SNY icon
23
Sanofi
SNY
$104B
$8.53M 1.1%
171,300
– –
CELG
24
DELISTED
Celgene Corp
CELG
$8.37M 1.08%
57,400
– –
ISRG icon
25
Intuitive Surgical
ISRG
$142B
$8.13M 1.05%
69,930
– –
1
2 3 4 5

Similar funds

QIM
Quest Investment Management Lake Oswego, Oregon $857M AUM 21.67% 1-Year Est. Return
NOCM
Night Owl Capital Management Greenwich, Connecticut $858M AUM 31.41% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return
EPIMS
Evelyn Partners Investment Management Services London $850M AUM 20.89% 1-Year Est. Return
BCM
Benchstone Capital Management New York $860M AUM 32.46% 1-Year Est. Return
PCM
Parsifal Capital Management Greenwich, Connecticut $849M AUM 28.52% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Hikari Power's Q3 2017 Portfolio in Review

As of Q3 2017, Hikari Power held 103 positions worth $774M, up 4.3% from $741M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Hikari Power's Q3 2017 filing shows 9 new, 21 increased, 5 reduced and 13 closed positions. Its largest new stake was Progenics Pharmaceuticals Inc: 200,000 shares worth $1.47M. The largest sale was Stericycle Inc, an estimated $6.93M.

By sector, the portfolio is most concentrated in Financials at 40% of assets, up from 39% a quarter earlier, followed by Healthcare and Technology.

  • Hikari Power's largest Q3 2017 buy was Progenics Pharmaceuticals Inc: 200,000 shares worth $1.47M.
  • Hikari Power added most to Synergy Pharmaceuticals, Inc Common Stock in Q3 2017, an estimated $3.41M increase.
  • Hikari Power's biggest Q3 2017 reduction was Stericycle Inc, cutting an estimated $6.93M.
  • Hikari Power fully exited Opko Health in Q3 2017, selling an estimated $917K.
  • Hikari Power's ten largest holdings make up 60% of its $774M portfolio in Q3 2017.
  • Hikari Power opened 9 new positions and closed 13 in Q3 2017.
  • Hikari Power's portfolio value rose 4.3% quarter-over-quarter to $774M.

Based on Hikari Power's 13F filing for Q3 2017, filed 8 Nov 2017.